These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11595569)

  • 21. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.
    Bristow MR; Gilbert EM; Abraham WT; Adams KF; Fowler MB; Hershberger RE; Kubo SH; Narahara KA; Ingersoll H; Krueger S; Young S; Shusterman N
    Circulation; 1996 Dec; 94(11):2807-16. PubMed ID: 8941106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR
    Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R; Basu S; Kinsey C; Schaeffer S; Lahiri A
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus.
    Nodari S; Metra M; Dei Cas A; Dei Cas L
    Eur J Heart Fail; 2003 Dec; 5(6):803-9. PubMed ID: 14675859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
    Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
    J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group.
    Yoshikawa T; Baba A; Suzuki M; Yokozuka H; Okada Y; Nagami K; Takahashi T; Mitamura H; Ogawa S
    Am J Cardiol; 2000 Jun; 85(12):1495-7; A7. PubMed ID: 10856401
    [No Abstract]   [Full Text] [Related]  

  • 31. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D; Bergemann A; Sliwa K; Candy G; Sareli P
    Circulation; 2001 Feb; 103(8):1083-8. PubMed ID: 11222470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
    Lou YF; Shi XP; Tong H; Yu GY; Yao GD; Dong K
    Circ J; 2009 Dec; 73(12):2363; author reply 2364. PubMed ID: 19940373
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
    Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY
    Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalization of left ventricular parameters following combined pimobendan and carvedilol treatment in a case of unclassified cardiomyopathy with longstanding refractory status.
    Takeda N; Ohtaki E; Misu K; Asano R; Tobaru T; Nagayama M; Kitahara K; Umemura J; Sumiyoshi T; Hosoda S
    Intern Med; 2002 Dec; 41(12):1147-52. PubMed ID: 12521204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.